Correlation Between Fulcrum Therapeutics and Crinetics Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both Fulcrum Therapeutics and Crinetics Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Fulcrum Therapeutics and Crinetics Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Fulcrum Therapeutics and Crinetics Pharmaceuticals, you can compare the effects of market volatilities on Fulcrum Therapeutics and Crinetics Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Fulcrum Therapeutics with a short position of Crinetics Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Fulcrum Therapeutics and Crinetics Pharmaceuticals.
Diversification Opportunities for Fulcrum Therapeutics and Crinetics Pharmaceuticals
-0.39 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Fulcrum and Crinetics is -0.39. Overlapping area represents the amount of risk that can be diversified away by holding Fulcrum Therapeutics and Crinetics Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Crinetics Pharmaceuticals and Fulcrum Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Fulcrum Therapeutics are associated (or correlated) with Crinetics Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Crinetics Pharmaceuticals has no effect on the direction of Fulcrum Therapeutics i.e., Fulcrum Therapeutics and Crinetics Pharmaceuticals go up and down completely randomly.
Pair Corralation between Fulcrum Therapeutics and Crinetics Pharmaceuticals
Given the investment horizon of 90 days Fulcrum Therapeutics is expected to generate 2.0 times less return on investment than Crinetics Pharmaceuticals. In addition to that, Fulcrum Therapeutics is 1.92 times more volatile than Crinetics Pharmaceuticals. It trades about 0.02 of its total potential returns per unit of risk. Crinetics Pharmaceuticals is currently generating about 0.09 per unit of volatility. If you would invest 3,327 in Crinetics Pharmaceuticals on September 3, 2024 and sell it today you would earn a total of 2,412 from holding Crinetics Pharmaceuticals or generate 72.5% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Fulcrum Therapeutics vs. Crinetics Pharmaceuticals
Performance |
| Timeline |
| Fulcrum Therapeutics |
| Crinetics Pharmaceuticals |
Fulcrum Therapeutics and Crinetics Pharmaceuticals Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Fulcrum Therapeutics and Crinetics Pharmaceuticals
The main advantage of trading using opposite Fulcrum Therapeutics and Crinetics Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Fulcrum Therapeutics position performs unexpectedly, Crinetics Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Crinetics Pharmaceuticals will offset losses from the drop in Crinetics Pharmaceuticals' long position.| Fulcrum Therapeutics vs. RAPT Therapeutics | Fulcrum Therapeutics vs. Mirum Pharmaceuticals | Fulcrum Therapeutics vs. BeyondSpring | Fulcrum Therapeutics vs. Stoke Therapeutics |
| Crinetics Pharmaceuticals vs. DiaMedica Therapeutics | Crinetics Pharmaceuticals vs. Lyra Therapeutics | Crinetics Pharmaceuticals vs. Centessa Pharmaceuticals PLC |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Latest Portfolios module to quick portfolio dashboard that showcases your latest portfolios.
Other Complementary Tools
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
| CEOs Directory Screen CEOs from public companies around the world | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges |